These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8170642)

  • 21. Immunoscintigraphy of colorectal cancer using a monoclonal antibody 77-1.
    Yiu CY; Baker LA; Davidson BR; McCready VR; Boulos PB
    Eur J Surg Oncol; 1991 Oct; 17(5):495-501. PubMed ID: 1936297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoscintigraphy of primary colorectal cancers with indium-111 monoclonal antibody B72.3.
    Joypaul BV; Kennedy N; Hanson J; Holley M; Browning M; Newman EL; Cuschieri A
    J R Coll Surg Edinb; 1994 Feb; 39(1):39-43. PubMed ID: 7515429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Indium 111-labeled antibodies in the detection of colorectal carcinoma].
    Artiko V; Obradović V; Davidović B; Petrović N; Petrović M; Krivokapić Z; Pavlov M; Adanja G; Sobić D; Vlajković M; Pavlović S; Rebić R
    Acta Chir Iugosl; 2003; 50(4):43-6. PubMed ID: 15307496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer.
    Petersen BM; Bass BL; Bates HR; Chandeysson PL; Harmon JW
    Am J Surg; 1993 Jan; 165(1):137-42; discussion 142-3. PubMed ID: 8418688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of hepatic metastases from colorectal carcinoma using indium-111 (111In) labeled monoclonal antibody (mAb): MSKCC experience with mAb 111In-C110.
    Divgi CR; McDermott K; Johnson DK; Schnobrich KE; Finn RD; Cohen AM; Larson SM
    Int J Rad Appl Instrum B; 1991; 18(7):705-10. PubMed ID: 1787079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunodetection of colorectal carcinoma.
    Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
    Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?
    Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP
    Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoscintigraphy with a new indium-111-labeled monoclonal antibody (MAb 1A3) in patients with colorectal cancer.
    Philpott GW; Siegel BA; Schwarz SW; Connett JM; Rocque PA; Fleshman JW; Wallis JW; Baumann M; Sun Y; Martell AE
    Dis Colon Rectum; 1994 Aug; 37(8):782-92. PubMed ID: 8055723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of immunoscintigraphy in the follow-up of surgically treated gastrointestinal carcinomas using 111In-labelled anti-CEA monoclonal antibodies.
    Cimitan M; Boz G; Spaziante R; Sorce P; De Paoli A; Baldoncini A; Borsatti E; Trovò MG; Zecchin R
    Clin Oncol (R Coll Radiol); 1992 Nov; 4(6):368-72. PubMed ID: 1463689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunoscintigraphy of colorectal carcinoma with a 111In-labelled anti-TAG-72 monoclonal antibody.
    Muxí A; Pons F; Herranz R; Novell F; Fernández R; Filella X; García A; Solá M; Trías M; Setoain J
    Nucl Med Commun; 1993 Sep; 14(9):775-87. PubMed ID: 8233243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioimmunoscintigraphy with 111In labelled monoclonal antibody fragments (F(ab')2 BW 431/31) against CEA: radiolabelling, antibody kinetics and distribution, findings in tumour and non-tumour patients.
    Bares R; Fass J; Truong S; Buell U; Schumpelick V
    Nucl Med Commun; 1989 Sep; 10(9):627-41. PubMed ID: 2616103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer. Correlation with computed tomography, surgery, histopathology, immunohistology, and human immune response.
    Winzelberg GG; Grossman SJ; Rizk S; Joyce JM; Hill JB; Atkinson DP; Sudina K; Anderson K; McElwain D; Jones AM
    Cancer; 1992 Apr; 69(7):1656-63. PubMed ID: 1551051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical relevance of anti-CEA immunoscintigraphy with the 99mTc-labelled monoclonal antibody BW 431/26. A critical assessment after 119 studies].
    Hach A; Wittig B; Piepenburg R; Steinert H; Lahmann C; Dippold W; Hahn K
    Rofo; 1992 Jul; 157(1):3-10. PubMed ID: 1638001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of unlabelled monoclonal antibody (MoAb) on biodistribution of 111indium labelled (MoAb).
    Lamki LM; Murray JL; Rosenblum MG; Patt YZ; Babaian R; Unger MW
    Nucl Med Commun; 1988 Aug; 9(8):553-64. PubMed ID: 3173914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic analysis of antibody localization in human colon cancer: comparison with immunoscintigraphy.
    Kubo A; Nakamura K; Katayama M; Hashimoto S; Teramoto T; Kodaira S
    Ann Nucl Med; 1992 Feb; 6(1):21-7. PubMed ID: 1520570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments.
    Goldenberg DM; Wlodkowski TJ; Sharkey RM; Silberstein EB; Serafini AN; Garty II; Van Heertum RL; Higginbotham-Ford EA; Kotler JA; Balasubramanian N
    J Nucl Med; 1993 Jan; 34(1):61-70. PubMed ID: 8418273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging of medullary carcinoma of the thyroid using 111In-labelled anti-CEA monoclonal antibody fragments.
    O'Byrne KJ; Hamilton D; Robinson I; Sweeney E; Freyne PJ; Cullen MJ
    Nucl Med Commun; 1992 Mar; 13(3):142-8. PubMed ID: 1557212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
    Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N
    Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.